President of Johnson & Johnson Development Corporation
Tom Heyman is President, Johnson & Johnson Development Corporation (JJDC), part of Johnson & Johnson Innovation. As head of JJDC, Tom will chair the board of JJDC, which represents the oldest and most reputable corporate venture fund in the life science industry. Tom will continue his position as CEO of Janssen Pharmaceutica NV in Belgium. He has been in this role since November 2008. Tom continues to be responsible for campus leadership in Beerse, Belgium, as well as the development and execution of a long-term organizational and talent strategy. Tom was appointed Chairman of the Board of Directors, Janssen Pharmaceutica in March 2012. He is a member of the Board of Directors VOKA, the Flemish Industry Association, Belgium, and a member of the Board of Directors of Innotek. As of April 2012, he is a member of the Board of Directors and the General Assembly of IMEC. Tom started his career with Johnson & Johnson in the Legal Department of Janssen Pharmaceutica NV in 1982, where he held a management position supporting legal and licensing activities. In 1990, Tom became Vice-President of Corporate Development at Ortho Pharmaceutical Corporation, and was appointed Head of Global Business Development for the Pharmaceutical Group in 1992, a position he held until March 31 2015. In his 25 years in Business Development, Tom and his Group entered into hundreds of transactions for both early and late stage Pharmaceutical products and technologies including IMBRUVUCA®, daratanumab, INVOKANA®, OLYSIO®, XARELTO®, VELCADE®, etc. He was also responsible for acquiring several key companies for J&J including Tibotec, Centocor, Cougar Pharmaceuticals, Aragon Pharmaceuticals, Covagen and Alios Biopharma. Tom has been a member of the Pharmaceuticals Group Operating Committee (GOC) from 1995 to 2015. From June 2007 until July 2009, Tom also served as Head of the CNS/IM Research & Early Development (RED) organization. He was born in the Congo, Africa, and graduated as Master of Law from the K.U. Leuven in Belgium. He continued with post-graduate studies in International Law in Geneva, Switzerland, and post-graduate studies in Business Management at the University of Antwerp in Belgium.
Follow Tom Heyman:
About Johnson & Johnson Development Corporation: Johnson & Johnson Development Corporation, a venture capital subsidiary, finances technology companies focused on patient health.